The virus is later killed and bottled into a vaccine. The vaccine can also be created within 10 to 12 weeks of identifying a pandemic strain -- half the time it takes to make egg-based vaccines. In December, Novavax studied low doses of its bird flu vaccine in a much smaller patient population.